# Zimmer Biomet Holdings, Inc.  Share Price Target ‘$131.17’, now 3.8% Upside Potential

- Link: https://www.directorstalkinterviews.com/zimmer-biomet-holdings-inc.share-price-target-131.17-now-3.8-upside-potential/4121141226
- Published: 2024-02-06T13:25:14+00:00
- Author: Charlotte Edwards

**Zimmer Biomet Holdings, Inc.** which can be found using ticker (ZBH) have now 
24 confirmed analysts covering the stock with the consensus suggesting a rating 
of ‘hold’. The range between the high target price and low target price is between
$149.00 and $105.00 suggesting an average analyst share price target price of $131.17.(
at the time of writing). Given that the stocks previous close was at $126.32 this
would indicate that there is a potential upside of 3.8%. The 50 day MA is $119.86
and the 200 day moving average is $124.19. The market capitalization for the company
is 26.20B. The stock price for the company is currently is currently $125.36 USD

 The potential market cap would be $27,203,713,377 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 55.47, revenue per share of $34.79
and a 4.21% return on assets.

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments
include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and 
markets orthopedic reconstructive products; sports medicine, biologics, extremities
and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical 
products; and a suite of integrated digital and robotic technologies that leverage
data, data analytics and artificial intelligence. Its other product category primarily
includes its robotic, surgical and bone cement products. Its products and solutions
help treat patients suffering from disorders of, or injuries to, bones, joints or
supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants,
Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip 
System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular 
System. Its S.E.T. product category includes sports medicine, biologics, foot and
others.

Share on: